BE884716A - Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes - Google Patents

Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes

Info

Publication number
BE884716A
BE884716A BE1/9927A BE1009927A BE884716A BE 884716 A BE884716 A BE 884716A BE 1/9927 A BE1/9927 A BE 1/9927A BE 1009927 A BE1009927 A BE 1009927A BE 884716 A BE884716 A BE 884716A
Authority
BE
Belgium
Prior art keywords
derivatives
triphenylpropene
triphenylpropane
preparation
pharmaceutical compositions
Prior art date
Application number
BE1/9927A
Other languages
English (en)
French (fr)
Original Assignee
Gyogyszerki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyogyszerki filed Critical Gyogyszerki
Publication of BE884716A publication Critical patent/BE884716A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2635Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving a phosphorus compound, e.g. Wittig synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/35Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
    • C07C17/354Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction by hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/003Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B22/00Buoys
    • B63B2022/006Buoys specially adapted for measuring or watch purposes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
BE1/9927A 1979-08-15 1980-08-11 Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes BE884716A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79GO1455A HU178253B (en) 1979-08-15 1979-08-15 Process for preparing 1,1,2-triphenyl-propane and -propane derivatives

Publications (1)

Publication Number Publication Date
BE884716A true BE884716A (fr) 1981-02-11

Family

ID=10996899

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9927A BE884716A (fr) 1979-08-15 1980-08-11 Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes

Country Status (22)

Country Link
JP (1) JPS5668637A (es)
AT (1) AT372074B (es)
BE (1) BE884716A (es)
BG (3) BG35032A3 (es)
CA (1) CA1179359A (es)
CH (1) CH649758A5 (es)
CS (1) CS241030B2 (es)
DD (1) DD152536A5 (es)
DE (1) DE3030802A1 (es)
DK (1) DK351780A (es)
ES (1) ES8104782A1 (es)
FI (1) FI74271C (es)
FR (1) FR2463121B1 (es)
GB (1) GB2058061B (es)
GR (1) GR69821B (es)
HU (1) HU178253B (es)
IT (1) IT1228130B (es)
NL (1) NL8004542A (es)
PL (3) PL131227B1 (es)
SE (1) SE450250B (es)
SU (3) SU1253426A1 (es)
YU (2) YU42980B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175188A1 (de) * 1984-09-11 1986-03-26 Nihon Tokushu Noyaku Seizo K.K. Carbamoylimidazol-Derivate
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
AU3879095A (en) * 1994-11-02 1996-05-31 Egis Gyogyszergyar Rt. Process and intermediates for preparing triphenyltrifluoropropanes and -propenes
WO1999008682A1 (en) 1997-08-15 1999-02-25 Duke University A method of preventing or treating estrogen-dependent diseases and disorders
CN1061334C (zh) * 1998-06-02 2001-01-31 中国科学院上海有机化学研究所 不饱和键三氟乙基化化合物的制备方法
US7935697B2 (en) * 2006-12-28 2011-05-03 Kinex Pharmaceuticals, Llc Compositions for modulating a kinase cascade and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (es) * 1962-09-13
US3712929A (en) * 1969-10-31 1973-01-23 Du Pont 1-perfluoroalkyl-1,2,2-triphenylethylenes

Also Published As

Publication number Publication date
BG35032A3 (en) 1984-01-16
FI802584A (fi) 1981-02-16
FI74271C (fi) 1988-01-11
DK351780A (da) 1981-02-16
BG34903A3 (en) 1983-12-15
YU206880A (en) 1983-12-31
PL131227B1 (en) 1984-10-31
YU42980B (en) 1989-02-28
SE450250B (sv) 1987-06-15
IT8024152A0 (it) 1980-08-14
SU1114332A3 (ru) 1984-09-15
HU178253B (en) 1982-04-28
YU43182B (en) 1989-04-30
ES494286A0 (es) 1981-04-16
FI74271B (fi) 1987-09-30
SU1253426A3 (ru) 1986-08-23
BG35031A3 (en) 1984-01-16
FR2463121B1 (fr) 1987-01-02
YU123983A (en) 1986-04-30
PL131226B1 (en) 1984-10-31
GR69821B (es) 1982-07-13
PL130386B1 (en) 1984-08-31
CS241030B2 (en) 1986-03-13
SU1253426A1 (ru) 1986-08-23
IT1228130B (it) 1991-05-28
NL8004542A (nl) 1981-02-17
GB2058061B (en) 1983-07-20
AT372074B (de) 1983-08-25
GB2058061A (en) 1981-04-08
CH649758A5 (de) 1985-06-14
DD152536A5 (de) 1981-12-02
JPS5668637A (en) 1981-06-09
CA1179359A (en) 1984-12-11
DE3030802A1 (de) 1981-03-12
DE3030802C2 (es) 1987-06-04
SU1097192A3 (ru) 1984-06-07
CS561680A2 (en) 1985-06-13
JPH0234933B2 (es) 1990-08-07
ATA419280A (de) 1983-01-15
FR2463121A1 (fr) 1981-02-20
PL226254A1 (en) 1983-01-17
ES8104782A1 (es) 1981-04-16
PL238085A1 (en) 1983-04-11
SE8005688L (sv) 1981-02-16

Similar Documents

Publication Publication Date Title
FR2511005B1 (fr) Procede de preparation de derives d'esters internes de gangliosides et compositions pharmaceutiques contenant ces derives
FR2466248B1 (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
PT78340A (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
BE868796A (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
BE881631A (fr) Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
BE862870A (fr) Nouveaux derives steroides 11 beta-substitues 1,3,5(10)-trieniques, procede de preparation et compositions pharmaceutiques
BE857138A (fr) Derives peptidiques, procede pour leur preparation et compositions therapeutiques contenant ces composes
BE864173A (fr) Nouveaux derives de 20,21-dinoreburnamenine, procede de preparation et compositions pharmaceutiques
BE884716A (fr) Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes
PT82364A (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
BE826711A (fr) Derives d'indolylacetylamino-acide, leur procede de preparation et les compositions pharmaceutiques contenant ces composes
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
BE877658A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
PT70005A (fr) Procede de preparation de nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime et des compositions pharmaceutiquesles contenant
BE875091A (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
BE884171A (fr) Nouveaux derives de l'ergol-8-ene et de l'ergoline, procede de preparation de ces derives et medicaments les contenant
PT75868A (fr) Procede de preparation de derives benzylideniques et de compositions pharmaceutiques les contenant
BE878256A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
PT74952A (fr) Procede de preparation de derives heterocycliques d'amidoximes et de compositions pharmaceutiques les contenant
PT70107A (fr) Procede de preparation de nouveaux derives de 1,3-benzoxazine-2,4-dione et des compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EGYT GYOGYSZERVE GYESZETI GYAR

Effective date: 19970831